Psychoneuroendocrinology of schizophrenia

Psychiatric Clinics of North America

Volumn 21, Issue 2, 1998, Pages 413-434

  Marx, C E ^a   Lieberman, J A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOHYPOPHYSIS HORMONE; APOMORPHINE; BACLOFEN; BRAIN DERIVED GROWTH FACTOR; BROMOCRIPTINE; CLONIDINE; CORTICOTROPIN; ESTROGEN; FENFLURAMINE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; HYDROCORTISONE; METHYLPHENIDATE; NERVE GROWTH FACTOR; NEUROHYPOPHYSIS HORMONE; NEUROLEPTIC AGENT; NEUROTROPHIN 3; OXYTOCIN; PRASTERONE SULFATE; PROGESTERONE; PROLACTIN; SEX HORMONE; TESTOSTERONE; VASOPRESSIN;

ADENOHYPOPHYSIS; CENTRAL NERVOUS SYSTEM; CHOLINERGIC SYSTEM; DOPAMINERGIC SYSTEM; GABAERGIC SYSTEM; HUMAN; HYPOTHALAMUS; NEUROENDOCRINOLOGY; NEUROHYPOPHYSIS; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SEX DIFFERENCE;

EID: 0031836049     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0193-953X(05)70013-7     Document Type: Article

References (172)

1. K. Abel V. O'Keane R. Murray Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients Br J Psychiatry 168 1996 57
2. M. Angermeyer J. Goldstein L. Kuhn Gender differences in schizophrenia: Rehospitalization and community survival Psychol Med 19 1989 365
3. C. Behl M. Widmann T. Trapp 17-beta-estradiol protects neurons from oxidative stress-induced cell death in vitro Biochem Biophys Res Commun 216 1995 473
4. C. Behl T. Skutella F. Lezoualc'h Neuroprotection against oxidative stress by estrogens: structure-activity relationship Mol Pharmacol 51 1997 535
5. F. Benes Development of the glutamate, GABA, and dopamine systems in relation to NRH-induced neurotoxicity Biol Psychiatry 38 1995 783
6. H. Biehl K. Maurer C. Schubart Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics-results of a prospective 5-year follow-up study European Archives of Psychiatry and Neurological Sciences 236 1986 139
7. R. Bosse T. Di Paolo The modulation of brain dopamine and GABA-A receptors by estradiol: A clue for CNS changes occurring at menopause Cell Mol Neurobiol 16 1996 199
8. F. Brambilla S. Marini A. Saito Noradrenergic and dopaminergic interrelation in schizophrenia Psychiatry Res 53 1994 231
9. A. Breier R. Buchanan The effects of metabolic stress on plasma progesterone in healthy volunteers and schizophrenic patients Life Sci 51 1992 1527
10. A. Breier O. Wolkowitz A. Doran Neurobiological effects of lumbar puncture stress in psychiatric patients and healthy volunteers Psychiatry Res 25 1988 187
11. T. Bridges E. Hillhouse M. Jones The effect of dopamine on neurohypophysial hormone release in vivo and from the rat neural lobe and hypothalamus in vitro J Physiol 260 1976 647
12. A. Brown W. Hembree J. Friedman The gonadal axis in men with schizophrenia Psychiatry Res 57 1995 231
13. G. Brown J. Cleghorn R. Kaplan Longitudinal growth hormone studies in schizophrenia Psychiatry Res 24 1988 123
14. D. Castle K. Abel N. Takei Gender differences in schizophrenia: Hormonal effect or subtypes? Schizophr Bull 21 1995 1
15. D. Castle R. Murray The neurodevelopmental basis of sex differences in schizophrenia Psychol Med 21 1991 565
16. D. Castle S. Wessely R. Murray Sex and schizophrenia: Effects of diagnostic stringency, and associations with premorbid variables Br J Psychiatry 162 1993 658
17. E. Cauter P. Linkowski M. Kerkhofs Circadian and sleep-related endocrine rhythms in schizophrenia Arch Gen Psychiatry 48 1991 348
18. D. Charney G. Heninger D. Sternberg Adrenergic receptor sensitivity in depression: Effects of clonidine in depressed patients and healthy subjects Arch Gen Psychiatry 39 1982 290
19. S. Checkley I. Glass C. Thompson The GH response to clonidine in endogenous as compared with reactive depression Psychol Med 14 1984 773
20. S. Checkley A. Slade E. Shur Growth hormone and other responses to clonidine in patients with endogenous depression Br J Psychiatry 138 1981 51
21. B. Cheng M. Mattson NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults Brain Res 640 1994 56
22. W. Coryell D. Tsuang Hypothalmic-pituitary-adrenal axis hyperactivity and psychosis: Recovery during an 8-year follow-up Am J Psychiatry 149 1992 1033
23. P. Cowell D. Kostianovsky R. Gur Sex differences in neuroanatomical and clinical correlations in schizophrenia Am J Psychiatry 153 1996 799
24. A. Davies R. McIvor R. Kumar Impact of childbirth on a series of schizophrenic mothers: A comment on the possible influence of oestrogen on schizophrenia Schizophr Res 16 1995 25
25. R. Davila M. Gonzalez M. Zumarraga Plasma prolactin and plasma homovanillic acid: Predictors of clinical response in schizophrenia Biol Psychiatry 38 1995 267
26. J. Deakin P. Slater M. Simpson Frontal cortical and left temporal glutamatergic dysfunction in schizophrenia J Neurochem 52 1989 1781
27. J. de Leon C. Verghese J. Tracy Polydipsia and water intoxication in psychiatric patients: A review of the epidemiological literature Biol Psychiatry 35 1994 519
28. T. Di Paolo Modulation of brain dopamine transmission by sex steroids Rev Neurosci 5 1994 27
29. T. Di Paolo R. Carmichael F. Labrie Effects of estrogens on the characteristics of [3H]spiperidol and [3H]RU24213 binding in rat anterior pituitary gland and brain Mol Cell Endocrinol 16 1979 99
30. T. Di Paolo M. Daigle F. Labrie Effect of estradiol and haloperidol on hypophysectomized rat brain dopamine receptors Psychoneuroendocrinology 9 1984 399
31. T. Di Paolo A. Dupont M. Daigle Effect of chronic estradiol treatment on dopamine concentrations in discrete brain nuclei of hypophysectomized female rats Neurosci Lett 32 1982 295
32. T. Di Paolo P. Poyet F. Labrie Effect of prolactin and estradiol on rat striatal dopamine receptors Life Sci 31 1982 2921
33. T. DiPaolo P. Payet F. Labrie Effect of chronic estradiol and haloperidol treatment on striatal dopamine receptors Eur J Pharmacol 73 1981 105
34. D. Dluzen V. Ramirez In vitro progesterone modulates amphetamine-stimulated dopamine release from the corpus striatum of castrated male rats treated with estrogen Neuroendocrinology 52 1990 517
35. A. Dupont T. Di Paolo B. Gagne Effects of chronic estrogen treatment on dopamine concentrations and turnover in discrete brain nuclei of overiectomized rats Neurosci Lett 22 1981 69
36. S. Faraone W. Chen J. Goldstein Gender differences in age at onset of schizophrenia Br J Psychiatry 164 1994 625
37. M. Foreman J. Porter Effects of catechol estrogens and catecholamines on hypothalamic and corpus striatal tyrosine hydroxylase activity J Neurochem 34 1980 1175
38. M. Forsling L. Iversen S. Lightman Dopamine and enkephalin directly inhibit vasopressin release from the neurohypophysis J Physiol 319 1981
39. D. Garver Neuroendocrine findings in schizophrenia Neurol Clin 6 1988 103
40. D. Garver G. Bisette J. Yao Relation of CSF neurotensin concentrations to symptoms and drug response of psychotic patients Am J Psychiatry 148 1991 484
41. G. Garyfallos G. Lavrentiadis D. Amoutzias Negative symptoms of schizophrenia and the dexamethasone suppression test Acta Psychiatr Scand 88 1993 425
42. W. Gattaz P. Vogel A. Riecher-Rossler Influence of the menstrual cycle phase on the therapeutic response in schizophrenia Biol Psychiatry 36 1994 137
43. A. Gazzaley N. Weiland B. McEwen Differential regulation of NMDAR1 mRNA and protein by estradiol in the rat hippocampus J Neurosci 16 1996 6830
44. M. Goldman G. Robertson D. Luchins Psychotic exacerbations and enhanced vasopressin secretion in schizophrenic patients with hyponatremia and polydipsia Arch Gen Psychiatry 54 1997 443
45. M. Goldman L. Blake R. Marks Association of nonsuppression of cortisol on the DST with primary polydipsia in chronic schizophrenia Am J Psychiatry 150 1993 653
46. J. Goldstein Gender differences in the course of schizophrenia Am J Psychiatry 145 1988 684
47. J. Goldstein B. Link Gender and the expression of schizophrenia J Psychiatric Res 22 1988 141
48. J. Gordon R. Borison B. Diamond Modulation of dopamine receptor sensitivity by estrogen Biol Psychiatry 15 1980 389
49. D. Guivarc'h P. Vernier J. Vincent Sex steroid hormones change the differential distribution of the isoforms of the D2 Dopamine receptor messenger RNA in the rat brain Neuroscience 69 1995 159
50. R. Gur R. Petty B. Turetsky Schizophrenia throughout life: Sex differences in severity and profile of symptoms Schizophr Res 21 1996 1
51. H. Häfner S. Behrens J. De Vry An animal model for the effects of estradiol on dopamine-mediated behavior: Implications for sex differences in schizophrenia Psychiatry Res 38 1991 125
52. J. Hallonquist M. Seeman M. Lang Variation in Symptom Severity over the menstrual cycle of schizophrenics Biol Psychiatry 33 1993 207
53. M. Hambrecht K. Maurer H. Hafner Evidence for a gender bias in epidemiological studies of schizophrenia Schizophr Res 8 1992 223
54. M. Harris D. Jeste Late-onset schizophrenia: An overview Schizophr Bull 14 1988 39
55. P. Harrison D. McLaughlin R. Kerwin Decreased hippocampal expression of a glutamate receptor gene in schizophrenia Lancet 337 1991 450
56. I. Heuser A. Yassouridis F. Holsboer The combined dexamethasone/CRH test: A refined laboratory test for psychiatric disorders J Psychiatr Res 28 1994 341
57. J. Hirschowitz R. Hitzemann G. Burr A new approach to dose reduction in chronic schizophrenia Neuropsychopharmacology 5 1991 103
58. R. Hruska M. Novak Estrogen treatment increases the density of D1 dopamine receptors in the rat striatum Brain Res 442 1988 349
59. R. Hruska E. Silbergeld Estrogen treatment enhances dopamine receptor sensitivity in the rat striatum Eur J Pharmacol 61 1980 397
60. R. Irwin S. Lin M. Rogawski Steroid potentiation and inhibition of N-methyl-D-aspartate receptor-mediated intracellular Ca++ responses: Structure-activity studies J Pharmacol Exp Ther 271 1994 677
61. D. Janowsky P. Leichner D. Parker The effect of methylphenidate on serum growth hormone Arch Gen Psychiatry 35 1978 1384
62. D. Javitt S. Zukin Recent advances in the phencyclidine model of schizophrenia Am J Psychiatry 148 1991 1301
63. N. Jiang M. Chopp D. Stein Progesterone is neuroprotective after transient middle cerebral artery occlusion in male rats Brain Res 735 1996 101
64. J. Jones D. Stein B. Stanley Negative and depressive symptoms in suicidal schizophrenics Acta Psychiatr Scand 89 1994 81
65. R. Kahn M. Davidson J. Hirschowitz Nocturnal growth hormone secretion in schizophrenic patients and healthy subjects Psychiatry Res 41 1992 155
66. R. Kathol T. Gehris B. Carroll Blunted ACTH response to hypoglycemic stress in depressed patients but not in patients with schizophrenia J Psychiatr Res 26 1992 103
67. N. Keks D. Copolov D. McKenzie Growth hormone response to clonidine in neuroleptic-free patients with multidiagnostically defined schizophrenia Psychiatry Res 48 1993 79
68. R. Kendell J. Chalmers C. Platz Epidemiology of puerperal psychoses Br J Psychiatry 150 1987 662
69. K. Kendler R. Weitzman R. Rubin Lack of arginine vasopressin response to central dopamine blockade in normal adults J Clin Endocrinol Metab 47 1978 204
70. R. Kerwin S. Patel B. Meldrum Quantitative autoradiographic analysis of glutamate binding sites in the hippocampal formation in normal and schizophrenic brain post mortem Neuroscience 39 1990 25
71. B. Kirkpatrick W. Carpenter K. Maeda Plasma prolactin as a predictor of relapse in drug-free schizophrenic outpatients Biol Psychiatry 32 1992 1049
72. T. Kolakowska P. Cowen P. Murdock Endocrine response to tryptophan infusion in schizophrenic patients treated with neuroleptics Psychoneuroendocrinology 12 1987 193
73. J. Kulkarni A. Castella D. Smith A clinical trial of the effects of estrogen in acutely psychotic women Schizophr Research 20 1996 247
74. S. Lal N. Nair Neuroendocrine evaluation of catecholamine function in man: Application to research in psychiatry and neurology J. Shah A. Donald Psychoneuroendocrine Dysfunction in Psychiatric and Neurological Illnesses: Influences of Psychopharmacological Agents 1983 Plenum Press New York 213 216
75. C. Lammers D. Garcia-Borreguero J. Schmider Combined dexamethason/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II Biol Psychiatry 38 1995 803
76. J. Leff N. Sartorius A. Jablensky The international pilot study of schizophrenia: Five-year follow-up findings Psychol Med 22 1992 131
77. J. Legros T. Gazzotti T. Carvelli Apomorphine stimulation of vasopressin- and oxytocin-neurophysins. Evidence for increased oxytocinergic and decreased vasopressinergic function in schizophrenics Psychoneuroendocrinology 17 1992 611
78. B. Lerer A. Ran M. Blacker Neuroendocrine responses in chronic schizophrenia Schizophr Res 1 1988 405
79. D. Levesque T. Di Paolo Rapid conversion of high into low striatal D2-dopamine receptor agonist binding states after an acute physiological dose of 17-beta-estradiol Neurosci Lett 88 1988 113
80. J. Lieberman A. Koreen Neurochemistry and neuroendocrinology of schizophrenia: A selective review Schizophr Bull 19 1993 371
81. J. Lieberman J. Alvir S. Geisler Methylphenidate response, psychopathology and tardive dyskinesia as predictors of relapse in schizophrenia Neuropsychopharmacology 11 1994 107
82. J. Lieberman D. Jody J. Ma Brain morphology, dopamine, and eye-tracking abnormalities in first-episode schizophrenia Arch Gen Psychiatry 50 1993 357
83. J. Lieberman D. Jody S. Geisler Time course and biologic correlates of treatment response in first-episode schizophrenia Arch Gen Psychiatry 50 1993 369
84. J. Lieberman Prediction of outcome in first-episode schizophrenia J Clin Psychiatry 54 1993 13
85. J. Lieberman B. Bogerts G. Degreef Qualitative assessment of brain morphology in acute and chronic schizophrenia Am J Psychiatry 149 1992 784
86. J. Lieberman J. Kane M. Woerner Prediction of relapse in schizophrenia Clin Neuropharmacol 13 1990 434
87. J. Lieberman J. Alvir M. Woerner Prospective study of psychobiology in first-episode schizophrenia at Hillside Hospital Schizophr Bull 18 1992 351
88. P. Linkowski V. Geenen M. Kerkhofs Cerebrospinal fluid neurophysins in affective illness and in schizophrenia European Archives of Psychiatry and Neurological Sciences 234 1984 162
89. S. Lipton P. Rosenberg Excitatory amino acids as a final common pathway for neurologic disorders N Engl J Med 330 1994 613
90. A. Loranger Sex differences in age at onset of schizophrenia Arch Gen Psychiatry 41 1984 157
91. R. Luggin L. Bernsted B. Petersson Acute psychiatric admission related to the menstrual cycle Acta Psychiatr Scand 69 1984 461
92. M. Mattson M. Lovell F. Katsutoshi Neurotrophic factors attenuate glutamate-induced accumulation of peroxides, elevation of intracellular Ca++ concentration, and neurotoxicity and increase antioxidant enzyme activities in hippocampal neurons J Neurochem 65 1995 1740
93. N. Matussek M. Ackenheil H. Hippius Effect of clonidine on growth hormone release in psychiatric patients and controls Psychiatry Res 2 1980 25
94. K. Maurer H. Hafner Methodological aspects of onset assessment in schizophrenia Schizophr Res 15 1995 265
95. M. Mauri A. Vita G. Giobbio Prediction of response to haloperidol in schizophrenia: Neuroendocrine, neuromorphological and clinical variables Int Clin Psychopharmacol 9 1994 3
96. D. Mayerhoff J. Lieberman C. Lemus Growth hormone response to growth hormone-releasing hormone in schizophrenic patients Am J Psychiatry 147 1990 1072
97. T. McNeil A prospective study of postpartum psychoses in a high-risk group Acta Psychiatr Scand 74 1986 205
98. W. Mendelson L. Jacobs J. Reichman Methysergide: Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion J Clin Invest 56 1975 690
99. R. Miranda F. Sohrabji D. Toran-Allerand Interactions of estrogen with the neurotrophins and their receptors during neural development Horm Behav 28 1994 367
100. M. Mokrani F. Duval M. Crocq Multihormonal responses to apomorphine in mental illness Psychoneuroendocrinology 20 1995 365
101. P. Monteleone M. Maj M. Iovino Baclofen-induced growth hormone secretion is blunted in chronic schizophrenics: Neuroendocrine evidence for a GABA disturbance in schizophrenia Psychiatry Res 26 1988 1
102. P. Monteleone A. Piccolo M. Martino Seasonal variation in the dexamethasone suppression test: A longitudinal study in chronic schizophrenics and in healthy subjects Neuropsychobiology 30 1994 61
103. F. Moos P. Richard Excitatory effect of dopamine on oxytocin and vasopressin reflex releases in the rat Brain Res 241 1982 249
104. D. Murphy M. Segal Regulation of dendritic spine density in cultured rat hippocampal neurons by steroid hormones J Neurosci 16 1996 4059
105. D. Nerozzi A. Magnani C. Dastoli Prolactin responses to domperidone in chronic schizophrenia Psychiatry Res 42 1992 159
106. D. Nerozzi A. Magnani V. Sforza Prolactin and growth hormone responses to growth hormone-releasing hormone in acute schizophrenia Neuropsychology 23 1990 15
107. J. Newcomer S. Riney S. Vinogradov Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia Psychiatry Res 41 1992 191
108. F. Nicoletti N. Ferrara F. Patti Influence of sex steroids and prolactin on haloperidol-induced catalepsy Brain Res 279 1983 352
109. K. Nomura F. Kurimoto H. Demura Effect of metoclopramine on plasma vasopressin in man Clin Endocrinol 21 1984 117
110. P. Nopoulos M. Flaum N. Andreasen Sex differences in brain morphology in schizophrenia Am J Psychiatry 154 1997 1648
111. R. Oades R. Schepker Serum gonadal steroid hormones in young schizophrenic patients Psychoneuroendocrinology 19 1994 373
112. V. O'Keane K. Abel R. Murray Growth hormone responses to pyridostigmine in schizophrenia: evidence for cholinergic dysfunction Biol Psychiatry 36 1994 582
113. J. Olney N. Farber Glutamate receptor dysfunction and schizophrenia Arch Gen Psychiatry 52 1995 998
114. A. Pakaslahti Prediction of working disability in schizophrenia: a 5-year prospective study of a representative cohort of first-admissions Publications of the Social Insurance Institution 119 1992 1
115. G. Pandey D. Garver C. Tamminga Postsynaptic supersensitivity in schizophrenia Am J Psychiatry 134 1977 518
116. G. Pandey R. Sharma P. Janicak Monoamine oxidase and cortisol response in depression and schizophrenia Psychiatry Res 44 1992 1
117. M. Park-Chung F. Wu D. Farb 3-alpha-5-beta-pregnan-20-one sulfate: A negative modulator of the NMDA-induced current in cultured neurons Mol Pharmacol 46 1994 146
118. S. Paul R. Purdy Neuroactive steroids FASEB J 6 1992 2311
119. C. Peabody M. Warner M. Griffin Prolactin bioassay in schizophrenia before and after neuroleptics Psychiatry Res 41 1992 249
120. C. Peabody M. Warner E. Markoff Growth hormone response to growth hormone releasing hormone in depression and schizophrenia Psychiatry Res 32 1990 269
121. R. Prudo Monroe-Blum Five-year outcome and prognosis in schizophrenia. A report from the London Field Research Centre of the International Pilot Study of Schizophrenia Br J Psychiatry 150 1987 345
122. R. Purdy L. Morrow P. Moore Stress-induced elevations of gamma-aminobutyric acid type A receptor-active steroids in the rat brain Proc Natl Acad Sci USA 88 1991 4553
123. V. Ramirez J. Zheng Membrane sex-steroid receptors in the brain Front Neuroendocrinol 17 1996 402
124. M. Rao B. Strebel A. Halaris Circadian rhythm of vital signs, norepinephrine, epinephrine, thyroid hormones, and cortisol in schizophrenia Psychiatry Res 57 1995 21
125. S. Reichlin Neuroendocrinology R. Williams Textbook of Endocrinology, ed 6 1981 Williams &Wilkins Baltimore, MD 589 645
126. A. Riecher K. Maurer W. Loffler Schizophrenia—A disease of young single males? European Archives of Psychiatry and Neurological Sciences 239 1989 210
127. A. Riecher-Rossler H. Hafner A. Dutsch-Strobel Further evidence for a specific role of estradiol in schizophrenia? Biol Psychiatry 36 1994 492
128. Riecher-Rössler H. Hafner Schizophrenia and oestrogens—is there an association? Eur Arch Psychiatry Clin Neurosci 242 1993 323
129. Riecher-Rössler H. Hafner M. Stumbaum Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 20 1994 203
130. A. Riggs M. Dysken W. Kim A review of disorders of water homeostasis in psychiatric patients Psychosomatics 32 1991 133
131. S. Risch R. Lewine N. Kalin Limbic-hypothalamic-pituitary-adrenal axis activity and ventricular-to-brain ratio studies in affective illness and schizophrenia Neuropsychopharmacology 6 1992 95
132. J. Rivier J. Spiess M. Thorner Characterization of a growth hormone releasing factor from a pancreatic islet tumor Nature 300 1982 1321
133. R. Roof R. Duvdevani L. Braswell Progesterone treatment attenuated brain edema following contusion injury in male and female rats Restor Neurol Neurosci 4 1992 425
134. J. Rybakowski M. Plocka Seasonal variations of the dexamethasone suppression test in depression compared with schizophrenia: A gender effect J Affect Disord 24 1992 87
135. S. Schlegel R. Schlosser C. Hiemke Prolactin plasma levels and D2 dopamine receptor occupancy measured with IBZM-SPECT Psychopharmacology 124 1996 285
136. M. Schumacher P. Robel E. Baulieu Development and regeneration of the nervous system: A role for neurosteroids Dev Neurosci 18 1996 6
137. M. Seeman Psychopathology in women and men: Focus on female hormones Am J Psychiatry 154 1997 1641
138. M. Seeman The role of estrogen in schizophrenia J Psychiatry Neurosci 21 1996 123
139. M. Seeman Sex differences in predicting neuroleptic response W. Gaebel A. Awad The Prediction of Neuroleptic Response 1995 Springer-Verlag Vienna 51
140. M. Seeman Current outcome in schizophrenia: Women vs. men Acta Psychiatr Scand 73 1986 609
141. V. Seybold J. Miller P. Lewis Investigation of a dopaminergic mechanism for regulating oxytocin release J Pharmacol Exp Ther 207 1978 605
142. R. Sharma J. Javaid G. Pandey Pharmacological effects of methylphenidate in plasma homovanillic acid and growth hormone Psychiatry Res 32 1990 9
143. R. Sharma J. Javaid G. Pandey Behavioral and biochemical effects of methylphenidate in schizophrenic and nonschizophrenic patients Biol Psychiatry 30 1991 459
144. A. Shimizu M. Kurachi M. Noda Influence of sex on age at onset of schizophrenia Jpn J Psychiatry Neurol 42 1988 35
145. D. Shtasel R. Gur F. Gallacher Gender differences in the clinical expression of schizophrenia Schizophr Res 7 1992 225
146. L. Siever T. Uhde E. Silberman Growth hormone response to clonidine as a probe of noradrenergic receptor responsiveness in affective disorder patients and controls Psychiatry Res 6 1982 171
147. J. Simpkins P. Green K. Gridley Fundamental role for estrogens in cognition and neuroprotection J. Brioni M. Decker Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations 1997 E Wiley-Liss, Inc New York 503
148. M. Simpson P. Slater M. Royston Alterations in phencyclidine and sigma binding sites in schizophrenic brains Schizophr Res 6 1992 41
149. C. Singer K. Rogers T. Strickland Estrogen protects primary cortical neurons from glutamate toxicity Neurosci Lett 212 1996 13
150. M. Singh E. Meyer J. Simpkins The effect of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger RNA expression in cortical and hippocampal brain regions of female Sprague-Dawley rats Endocrinology 136 1995 2320
151. P. Sirota I. Gil-Ad H. Hermesh Growth hormone response to TRH in families multiply affected with schizophrenia Biol Psychiatry 31 1992 1241
152. S. Skare M. Dysken C. Billington A review of GHRH stimulation test in psychiatry Biol Psychiatry 36 1994 249
153. S. Szymanski J. Lieberman J. Alvir Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients Am J Psychiatry 152 1995 5
154. R. Tandon C. Lewis S. Taylor Relationship between DST nonsuppression and shortened REM latency in schizophrenia Biol Psychiatry 40 1996 660
155. R. Thara A. Rajkumar Gender differences in schizophrenia: Results of a follow-up study in India Schizophr Res 7 1992 65
156. C. Toran-Alleran Mechanisms of estrogen action during neural development: Mediation by interactions with the neurotrophins and their receptors? J Steroid Biochem Mol Biol 56 1996 1
157. C. Toran-Allerand The estrogen/neurotrophin connection during neural development: Is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant? Dev Neurosci 18 1996 36
158. C. Toran-Allerand K. Hashimoto W. Greenough Sex steroids and the development of the newborn mouse hypothalamus and preoptic area in vitro III: Effects of estrogen on dendritic differentiation Brain Res 283 1 1983 97
159. D. Treit Animal models for the study of anti-anxiety agents: A review Neuroscience and Biobehavioral Reviews 9 1985 203
160. E. Van Cauter P. Linkowski M. Kerkhofs Circadian and sleep-related endocrine rhythms in schizophrenia Arch Gen Psychiatry 48 1991 343
161. T. Van Putten S. Marder J. Mintz Serum prolactin as a correlate of clinical response to haloperidol J Clin Psychopharmacol 11 1991 357
162. E. Vizy V. Volbekas Inhibition by dopamine of oxytocin release from isolated posterior lobe of the hypophysis of the rat; disinhibitory effect of beta-endorphin/enkephalin Neuroendocrinology 31 1980 46
163. V. Wahby G. Ibrahim E. Giller Thyrotropin response to thyrotropin-releasing hormone in RDC schizodepressed men J Affect Disord 15 1988 81
164. V. Wahby G. Ibrahim I. LeeChuy Prolactin response to thyrotropin-releasing hormone in schizoaffective depressed compared to depressed and schizophrenic men and healthy controls Schizophr Res 3 1990 277
165. J. Wass Growth hormone neuroregulation and the clinical relevance of somatostatin Clin Endocrinol Metab 12 1983 695
166. I. Wickelgren Estrogen stakes claim to cognition Science 276 1997 675
167. G. Wik Effects of neuroleptic treatment on cortisol and 3-methoxy-4-hydroxyphenylethyl glycol levels in blood J Endocrinol 144 1995 425
168. G. Wik Energy metabolism in the hypothalamus and plasma cortisol levels in patients with schizophrenia Horm Metab Res 28 1996 205
169. C. Woolley N. Weiland B. McEwen Estradiol increases the sensitivity of hippocampal CA1 pyramidal cells to NMDA receptor-mediated synaptic input: Correlation with dendritic spine density J Neurosci 17 1997 1848
170. F. Zemlan J. Hirschowitz D. Garver Relation of clinical symptoms to apomorphine-stimulated growth hormone release in mood-incongruent psychotic patients Arch Gen Psychiatry 43 1986 1162
171. E. Zigler M. Glick A. Marsh Premorbid social competence and outcome among schizophrenic and nonschizophrenic patients J Nerv Ment Dis 167 1979 478
172. E. Zigler J. Levine B. Zigler Premorbid social competence and paranoid-nonparanoid status in female schizophrenic patients J Nerv Ment Dis 164 1977 333